Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Polyclonal Antibody to Tumor Necrosis Factor Ligand Superfamily, Member 7 (TNFSF7)

Product Specifications

Gene Name

[TNFSF7]

NCBI Gene ID

970

Reactivity

Human

Storage Conditions

Storage: Avoid repeated freeze/thaw cycles.<br>Store at 4ºC for frequent use.<br>Aliquot and store at -20ºC for 12 months.<br>Stability Test: The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Other Gene Names

[CD70; CD70; CD27L; CD27-L; CD27LG; TNFSF7; TNLG8A; CD27L; CD27LG; TNFSF7; CD27-L]

Short Name

[Tumor Necrosis Factor Ligand Superfamily, Member 7 (TNFSF7)]

Other Product Names

[CD70 antigen isoform 1; CD70 antigen; CD70 antigen; CD70 molecule; CD27 ligand; CD27-L; Tumor necrosis factor ligand superfamily member 7; CD_antigen: CD70]

NCBI GI Number

4507605

NCBI Accession Number

NP_001243.1

NCBI GB Accession Number

NM_001252.4

Uniprot Accession Number

O55237

CAS Number

9007-83-4

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Anti-Phospho-p57 (T310) CDKN1C Antibody
A01244T310 100 µL

Anti-Phospho-p57 (T310) CDKN1C Antibody

Ask
View Details
EIF3H Antibody - N-terminal region: HRP (ARP50491_P050-HRP)
ARP50491_P050-HRP 100 µL

EIF3H Antibody - N-terminal region: HRP (ARP50491_P050-HRP)

Ask
View Details
HMG-20A (D-5):m-IgG1 BP-HRP Bundle
sc-533039 1 Kit

HMG-20A (D-5):m-IgG1 BP-HRP Bundle

Ask
View Details
C3orf70 Antibody - C-terminal region: Biotin (ARP69615_P050-Biotin)
ARP69615_P050-Biotin 100 µL

C3orf70 Antibody - C-terminal region: Biotin (ARP69615_P050-Biotin)

Ask
View Details
CCDC184 (h)-PR
sc-95826-PR 10 µM, 20 µL

CCDC184 (h)-PR

Ask
View Details